Spyridon Papapetropoulos

Director, Adamas Pharmaceuticals (United States).

Companies

Neuphoria Therapeutics Inc.President Apr 18, 2025 to now¹
Neuphoria Therapeutics Inc.Board member Jul 8, 2024 to now²
Neuphoria Therapeutics Inc.Chief executive officer Jul 8, 2024 to now²
Lipocine Inc.Board member Apr 12, 2022 to now³
Vigil Neuroscience, Inc.Chief Medical Officer Jan 6, 2022 to Nov 22, 2022⁴
Adamas Pharmaceuticals (United States)Board member Nov 24, 2020 to Nov 24, 2021⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Neuphoria Therapeutics Inc. NEUP5,999,940 shares⁶$20.0M at $3.33Jul 8, 2024
Lipocine Inc. LPCN21,739 shares⁷$31.7K at $1.46Nov 22, 2022
Adamas Pharmaceuticals (United States)0 shares⁸Nov 24, 2021
Vigil Neuroscience, Inc.4,000 shares⁹Nov 18, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 22, 2022Bought 21,739 shares at $0.47 of Lipocine Inc.⁷
Nov 18, 2022Sold 300 shares at $14.00 of Vigil Neuroscience, Inc.⁹
Nov 18, 2022Exercised options 300 shares at $1.89 of Vigil Neuroscience, Inc.⁹
May 3, 2022Bought 4,000 shares at $3.40 of Vigil Neuroscience, Inc.¹⁰
Nov 24, 2021U 20,975 shares of Adamas Pharmaceuticals (United States)⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNeuphoria Therapeutics Inc., President
2
SEC EDGARNeuphoria Therapeutics Inc., Board member
3
SEC EDGARLipocine Inc., Board member
4
SEC EDGARVigil Neuroscience, Inc., Chief Medical Officer
5
SEC EDGARAdamas Pharmaceuticals (United States), Board member
6
SEC EDGARNeuphoria Therapeutics Inc. shares after the filing of Jul 8, 2024
7
SEC EDGARLipocine Inc. shares after the filing of Nov 22, 2022
8
SEC EDGARAdamas Pharmaceuticals (United States) shares after the filing of Nov 24, 2021
9
SEC EDGARVigil Neuroscience, Inc. shares after the filing of Nov 18, 2022
10
SEC EDGARForm 4 filed May 4, 2022